Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Since launch of ‘Hepatitis C: State of Medicaid Access’ in 2017, more than half still impose some form of illegal restriction
This hales another victory for improved treatment for hepatitis C.
September 4, 2019, the U.S. FDA released their recent approval of new dosage forms of Sovaldi and Harvoni for children 3 to 12 years of age.
A dangerous step anyone can take against their health is assume they don’t have hepatitis C.
Tips on how to talk to your doctor about hepatitis C.
Do you wonder if the medicines and other substances you take interact with each other? For more about this, read Ask Hep.
The former Soviet country has suffered through one of the highest rates of HCV in the world.
Lucinda Porter discusses the last chapter of her hepatitis C story.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
A look at recovering from hepatitis C treatment, and why it may differ among people.
However, many providers did not see such benefits—raising questions about whether drug pricing deals improve access to care.
Researchers found that this association was statistically significant beginning five years after treatment.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
Resources to help hepatitis C patients and their families get the proper, affordable medical and treatment assistance they need.
A look at the risks and rewards of hepatitis C treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.